Metabolic pathways |
63 |
1061 |
−4.31 |
Cytokine-cytokine receptor interaction |
54 |
232 |
7.49 |
Chemokine signaling pathway |
42 |
173 |
6.89 |
Cell adhesion molecules (CAMs) |
34 |
131 |
6.64 |
Natural killer cell mediated cytotoxicity |
33 |
124 |
6.71 |
Endocytosis |
30 |
201 |
2.79 |
Systemic lupus erythematosus |
28 |
81 |
7.88 |
Antigen processing and presentation |
24 |
71 |
7.15 |
Chagas disease |
23 |
102 |
4.64 |
Leishmaniasis |
22 |
66 |
6.75 |
Viral myocarditis |
22 |
72 |
6.24 |
Graft-versus-host disease |
21 |
38 |
9.78 |
Jak-STAT signaling pathway |
20 |
138 |
2.12 |
T cell receptor signaling pathway |
20 |
107 |
3.37 |
Type I diabetes mellitus |
20 |
44 |
8.28 |
Allograft rejection |
19 |
38 |
8.66 |
Leukocyte transendothelial migration |
19 |
114 |
2.73 |
Vascular smooth muscle contraction |
19 |
122 |
2.4 |
Autoimmune thyroid disease |
18 |
49 |
6.63 |
Neuroactive ligand-receptor interaction |
17 |
285 |
−2.01 |
Fc gamma R-mediated phagocytosis |
16 |
87 |
2.93 |
Hematopoietic cell lineage |
16 |
79 |
3.37 |
B cell receptor signaling pathway |
14 |
76 |
2.75 |
Intestinal immune network for IgA production |
14 |
43 |
5.26 |
Malaria |
13 |
47 |
4.34 |
NOD-like receptor signaling pathway |
12 |
55 |
3.2 |
Asthma |
9 |
25 |
4.6 |
Primary immunodeficiency |
9 |
34 |
3.45 |
Prion diseases |
9 |
34 |
3.45 |
Alzheimer's disease |
7 |
154 |
−2.07 |
Circadian rhythm - mammal |
5 |
13 |
3.62 |
Huntington's disease |
5 |
160 |
−2.74 |
Ubiquitin mediated proteolysis |
5 |
134 |
−2.26 |